Showing results (1731-1740 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|December 23, 2006
Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancersJuro Nakanishi, Yoshihiro Wada, Koichiro Matsumoto, et al.
Cancer Immunology, Immunotherapy : CII|December 13, 2006
NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivoMartin A Grundy, Tong Zhang, Charles L Sentman
Cancer Immunology, Immunotherapy : CII|December 13, 2006
CD20-specific antibody-targeted chemotherapy of non-Hodgkin's B-cell lymphoma using calicheamicin-conjugated rituximabJohn F Dijoseph, Maureen M Dougher, Douglas C Armellino, et al.
Cancer Immunology, Immunotherapy : CII|December 30, 2006
The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinomaEirikur Saeland, Sandra J van Vliet, Malin Bäckström, et al.
Cancer Immunology, Immunotherapy : CII|August 2, 2007
Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cellsElizabeth P Ryan, Timothy P Bushnell, Alan E Friedman, et al.
Cancer Immunology, Immunotherapy : CII|July 20, 2007
Plant-derived EpCAM antigen induces protective anti-cancer responseRobert Brodzik, Sergei Spitsin, Max Golovkin, et al.
Cancer Immunology, Immunotherapy : CII|July 20, 2007
EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cellsHidenobu Ochiai, Gary E Archer, James E Herndon, et al.
Cancer Immunology, Immunotherapy : CII|July 5, 2007
Activation and route of administration both determine the ability of bone marrow-derived dendritic cells to accumulate in secondary lymphoid organs and prime CD8+ T cells against tumorsStephanie P Huck, Shiau-Choot Tang, Kate A Andrew, et al.
Cancer Immunology, Immunotherapy : CII|September 15, 2006
Increased blood spermine levels decrease the cytotoxic activity of lymphokine-activated killer cells: a novel mechanism of cancer evasionYoshihiko Kano, Kuniyasu Soda, Takeshi Nakamura, et al.
Cancer Immunology, Immunotherapy : CII|September 22, 2006
Selective identification of HLA-DP4 binding T cell epitopes encoded by the MAGE-A gene familyXiao-Fei Wang, William M Cohen, Florence A Castelli, et al.
Pageof 652